The present invention relates to substituted dihydroimidazopyridinedione compounds of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative, angiogenesis disorders, inflammatory diseases or diseases associated with inflammatory pain, as a sole agent or in combination with other active ingredients.本發明係關於如本文描述及定義之通式(I)之經取代二氫咪唑并吡啶二酮化合物，係關於製備該等化合物之方法，係關於適用於製備該等化合物之中間化合物，係關於包含該等化合物之醫藥組合物及組合及係關於該等化合物作為唯一藥劑或與其他活性成分組合以用於製造針對疾病(特定言之，過度增生、血管生成失調症、炎症性疾病或與炎症疼痛相關聯之疾病)之治療或預防之醫藥組合物之用途。
